NCT06615908View on ClinicalTrials.gov

Treatment of Persistent Post-concussive Symptoms With Psilocybin Assisted Therapy

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

March 30, 2027

Conditions
Persistent Post-concussive Symptoms
Interventions
DRUG

Psilocybin

See treatment arm description.

Trial Locations (1)

T2N 2T9

RECRUITING

University of Calgary, Calgary

All Listed Sponsors
collaborator

University of British Columbia

OTHER

lead

University of Calgary

OTHER